Breaking News

Corgenix, EDP Biotech In Diagnostic Test Pact

July 12, 2013

To manufacture and supply ColoMarker test

Corgenix Medical Corp., a developer and marketer of diagnostic test kits, has entered into a contract manufacturing agreement with EDP Biotech to manufacture and supply the ColoMarker diagnostic test, a blood test developed to detect the early stages of colon cancer. Corgenix recently expanded its contract services business unit.
 
“We are pleased to enter into this mutually beneficial relationship with EDP,” said Douglass Simpson, president and chief executive officer of Corgenix. “This reflects our strategic focus on the Contract Services portion of our business for diagnostic products, and it meets the increasing demand overall for contract services in the medical device and biotechnology industries.”

Related Contract Manufacturing:

Related Packaging:

Related Compliance:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks